Bausch & Lomb Corp (BLCO) Market Cap & Valuation Ratios
Bausch & Lomb Corp (BLCO) has a market cap of $6.2B and a price-to-sales ratio of 1.2, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
BLCOBausch & Lomb CorpFollow BLCO — free
—
Price chart with a free account
- Market cap
- 6.2B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 28 Oct, in 4 days
Peers
medical instruments & supplies · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| BLCO | 6.2 | — | 2.1 | 15.0 | 2.2% | +9% | 6% | 2% |
| ALGN | 11 | 26.9 | 2.4 | 12.3 | 5.8% | +4% | 13% | 13% |
| RGEN | 10.0 | 242.4 | 12.4 | 67.8 | 1.1% | +16% | 8% | 3% |
| ATR | 8.0 | 22.8 | 2.3 | 11.7 | 3.9% | +9% | 12% | 10% |
| TFX | 5.8 | — | 3.7 | 43.0 | 2.9% | +31% | 2% | 0.6% |
| MMSI | 5.6 | 38.4 | 3.7 | 18.0 | 3.6% | +10% | 13% | 8% |
| MMED | 5.2 | — | 1.5 | — | -6.1% | +14% | -5% | -5% |
| MMEDV | 5.0 | — | — | — | — | +14% | -5% | -5% |
| ICUI | 4.2 | — | 2.4 | 18.7 | 3.7% | -9% | 3% | 1% |
| NVST | 3.8 | 40.7 | 1.4 | 10.5 | 6.5% | +12% | 10% | 3% |
| PLSE | 3.8 | — | — | — | -1.6% | — | — | — |
| Median of these 10 | 38.4 | 2.4 | 18.0 | 3.6% | +12% | 8% | 3% |
; EV/Sales 2.1 vs. 2.4.
Growth vs. price
each dot a company · hover or tap for valuesBLCO and TFX and MMED and MMEDV and ICUI and PLSE have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
Bausch & Lomb Corp — questions
- What is Bausch & Lomb Corp's market cap?
- $6.2B.
- What is Bausch & Lomb Corp's price-to-sales ratio?
- 1.2.
Every figure on this page comes from Bausch & Lomb Corp's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.